search
for
 About Bioline  All Journals  Testimonials  Membership  News


European Journal of General Medicine
Medical Investigations Society
ISSN: 1304-3897
Vol. 1, Num. 1, 2004, pp. 14-18

European Journal of General Medicine, Vol. 1, No. 1, Jan-Mar, 2004, pp. 14-18

ORIGINAL ARTICLE

ANALYSIS OF CARCINOEMBRYONIC ANTIGEN, NEURON SPECIFIC ENOLASE, CYTOKERATIN 21-1 AND FERRITIN LEVELS IN COAL MINERS

Ferah Armutçu1, Remzi Altın2, Ahmet Gürel1, Levent Kart2, Murat Unalacak3, Arif H Çımrın4

Karaelmas University, Faculty of Medicine, Departments of Biochemistry1, Pulmonary Medicine2, Family Practice3, Dokuz Eylül University, Faculty of Medicine, Department of Pulmonary Medicine4
Correspondence: Dr.Ferah Armutcu Zonguldak Karaelmas University Department of Biochemistry, 67600 Zonguldak/ Turkey Fax: +90 372 2610155 Phone: +90 372 2610169 E-mail: drferah@yahoo.com

Code Number: gm04005

Coal miners have an increased risk of pneumoconiosis. Tumor markers that are used in screening, diagnosis and follow-up of lung cancers are also useful to distinguish malignant and benign lung disorders. Carcinoembriyonic antigen, neurone specific enolase, cytokeratin 21-1 and ferritin were studied to compare and examine the possible contribution of CEA, NSE and CYFRA in the diagnosis of early and low-grade pneumoconiosis in coal miners with (34 cases) or without pneumoconiosis (27 cases). There were statistically significant differences between groups concerning NSE and ferritin levels (p<0.001, p<0.001 respectively). No difference was obtained for CYFRA 21-1 and CEA (p<0.05). The relationship of NSE with age and smoking was investigated, but no correlation was found (r=0.224, p=0.204; r=0.291, p=0.095 respecitvely). However, there was a positive correlation between NSE and exposure duration (r=0.425, p=0.012). Similarly, there was no relationship between ferritin levels and age or smoking (r=0.230, p=0.191; r=0.248, p=0.158 respectively), but there was a positive correlation with exposure duration (r=0.390, p=0.023). In conclusion, NSE and ferritin were found to be higher in coal miners with pneumoconiosis. According to these results, tumor markers are neither sensitive nor specific enough for the determination of early and low grade pneumoconiosis. One of the interesting and important findings of this study is that NSE values were higher than 12.5 µg/mL in most of the pneumoconiosis cases (%73.5). So, the NSE cut-off value used in cancer screening of coal workers with pneumoconiosis should increased.

Key words: CEA, CYFRA 21-1, NSE, ferritin, pneumoconiosis, coal workers.

INTRODUCTION

Coal worker’s pneumoconiosis (CWP) is characterized by coal dust inhalation, deposition in the lungs, and tissue reaction to coal particles (1). The risk of pneumoconiosis is higher in coal miners (2). Tumor markers are used in screening, diagnosis and discrimination of malign and benign lesions of the lung (3,4). In recent studies, it is pointed out that CEA, NSE and CYFRA may be used in the diagnosis of benign pulmonary lesions (5,6,7). In this sudy, we aimed to compare examine the possible contribution of CEA, NSE and CYFRA in the diagnosis of early and low-grade pneumoconiosis in coal miners, with or without pneumoconiosis.

MATERIAL AND METHODS

Patients

The study was performed between June and August 2002 in Zonguldak Karaelmas University Hospital. Early and low grade pneumoconiosis cases (n:34) and controls without pneumoconiosis (n:27) were randomly selected among coal miners. Profusions of pneumoconiosis cases were between 0/1 to 2/2 according to ILO 1980 classification (8).

All cases were male. Chest X-ray and pulmonary function tests were performed to rule out lung cancer, COPD, asthma and tuberculosis etc. Workers who had any infection in the previous month were excluded from the study.

To obtain the data of demographic features and smoking history, a questionnaire was filled by a chest physician for each worker. Informed written consent was obtained from all subjects.

Table 1. The demographic features of pneumoconiosis and non-pneumoconiosis coal workers ( mean±SD)

Pneumoconiosis Non-Pneumoconiosis p value
n:34 n:27
Age (years) 43.8±4.8 42.9±3.7 >0.05
Range (years) 33-49 32-48
Exposure duration (years) 14.9±3.6 13.7±4.7 > 0.05
Range (years) 9-23 13-24
Smoking 27/34 (79.4 %) 19/27 (70.4 %) > 0.05
Cumulative cigarette smoking* 16.0 ± 10.3 16.5 ± 5.9 > 0.05
Range 5-45 10-30

*smoker cases

Tumor markers

Five cc venous blood was taken from each worker after 12 hours fasting and stored at -20 Co. NSE, CEA, CYFRA 21-1 and ferritin levels were measured by electrochemiluminescence methods by using commercial kits (Elecsys 2010 immunassay, Roche Diagnostics, USA).

Statistical analysis

Analytic results were obtained by using SPSS programme (11.0 version, SPSS Inc., Chicago, IL, USA). The difference between the means of variables in two groups was tested by Mann-Whitney U test (nonparametric). The relationship between tumor markers and age, smoking and exposure duration were analysed by Spearman correlation test. Significance was set at 5% level (p< 0.05). All measured values were given as mean ± SD (standard deviation).

RESULTS

Demographic characteristics of the coal workers are given in Table 1. There was no difference concerning age, smoking and exposure duration between coal workers with or without pneumoconiosis (p>0.05). The measurements of CEA, NSE, CYFRA 21-1 and ferritin levels are shown in Table 2.

When NSE and ferritin levels were analyzed there were statistical differences between groups (p<0.001, p<0.001 respectively; figure 1 and 2). However, no difference was obtained for CEA and CYFRA 21-1 (p>0.05). The relationship between NSE and age, smoking and exposure duration were investigated. There was a positive correlation for exposure duration (r=0.425, p=0.012), but no correlation was found for age and smoking (r=0.224, p=0.204; r=0.291, p=0.095, respectively). Similar results were obtained for ferritin levels and age (r=0.230, p=0.191), smoking (r=0.248, p=0.158, respectively) and exposure duration (r=0.390, p=0.023).

The cut-off value of NSE used to distinguish malign and benign lesions is accepted as 12.5 µg/mL. According to our data, the number of cases over 12.5 µg/mL was 25/34 (73.5%) in the group with pneumoconiosis and 11/27 (40.7%) in workers without pneumoconiosis. If the value of 12.5 µg/mL was taken as the reference cut-off, the sensitivity of NSE was found to be 70.6% and specificity to be 61.5%.

From the study results, the cut –off value to distinguish coal miers without pneumoconiosis and early and low grade pneumoconiosis was found as 16.5 µg/mL.

Table 2. The comparison of NSE, CEA, CYFRA 21-1 ve ferritin measurements in coal workers with pneumoconiosis and non-pneumoconiosis (mean±SD)

NSE* CEA** CYFRA-21** Ferritin*
(µg/mL) (µg/L) (ng/mL) (µg/L)
Pneumoconiosis 14.9±3.2 2.7±1.2 1.3±0.5 141±51
Non-pneumoconiosis 12.2±2.1 2.2±0.8 1.2±0.4 96±42

*p<0.001, **p>0.05

In this case, sensitivity and specifity were 65% and 81.3% respectively.

DISCUSSION

Coal workers’pneumoconiosis (CWP) is characterized by coal dust inhalation, deposition in the lungs and tissue reaction to coal particles. There may be no symptoms in early and low grade CWP (1). Additionally, there are inter and intra reader differences in chest X-ray evaluation (9,10). CEA, NSE, CYFRA 21-1 and ferritin, used in lung cancer diagnosis, have also been found increased in benign lung diseases (11,12). In the literature, there are no data that these tumor markers are used to distinguish early and low-grade pneumoconiosis.

Carcinoembryonic antigen is used in the diagnosis of colorectal, gastrointestinal, breast and lung cancers. It is found to be elevated in some benign diseases such as cirrhosis (45%), pulmonary emphysema (30%), rectal polyps (5%), benign breast diseases (15%) and ulcerative colitis (15%) (11,13). In our study, although there was a proportional difference between pneumoconiosis and non-pneumoconiosis cases, it was not statistically significant (p>0.05).

Neuron specific enolase is a glycolytic enzyme also known as phosphopyruvatehydr atase. It is found in neuroendocrine cells that have precursor uptake and decarboxilation.

It is detected in neuroendocrine tumors (SCLC, neuroblastoma, pheochromacytoma, carcinoid, thyroid medullary carcinoma and pancreatic neuroendocrine tumors).

The cut-off value for NSE is 12.5 µg/mL (14). NSE is especially important in staging of small cell lung cancer. It is increased in 60-81% of SCLC patients. An increased NSE level has also been shown in benign lung diseases (15).

There was a statistically significant difference of NSE level between pneumoconiosis and non-pneumoconiosis cases (p<0.001). If the value of 12.5 µg/ mL was taken as reference, the sensitivity was found to be 70.6% and specificity to be 61.5%. From the study results, the cut –off value to distinguish coal miers without pneumoconiosis and early and low grade pneumoconiosis was found as 16.5 µg/mL. In this case, sensitivity and specifity were 65% and 81.3% respectively.

When correlation analyses were performed between NSE and age, smoking and exposure duration, it was shown that the only statistical difference was obtained for exposure duration.

As the number of study cases was low in number, this might affect the results about smoking. On the other hand, as our study cases were in middle age, it is reasonable to expect that age did not affect the results. In our study, cut-off values were exceeded in 25 of 34 (73.5%) cases.

Cut-off values are important in differentiation of malign and benign diseases. These values may change according to the methods and kits used. In the study of Pina et. al., NSE cut-off values were measured as 9.8 µg/mL by EIA method in lung cancer screening patients (16). Kuralay et al. found this cut-off value as 8.7 µg/mL by EIA in malign and benign pleural effusions (12). In our study, we used an electrochemiluminescence method and, according to this method, the accepted cut-off level was as 12.5 µg/mL. From our results, it is possible to say that the NSE cut-off level must be taken higher than 12.5 µg/mL in patients with early and low grade pneumoconiosis in discrimination of malign and benign lesions.

Ferritin, one of the tumor markers, is also a nonspecific acute phase reactant, which increases in case of inflammation, infection, trauma and cancer. The reference interval for adults is 20-250 µg/L (11,17). There was a statistically significant difference of ferritin levels between pneumoconiosis and non-pneumoconiosis cases (p<0.001). But, as only a few workers had high levels of ferritin over 250 µg/L (only two cases), it seems that ferritin may not be useful in discrimination of normal coal workers without pneumoconiosis and coal workers with early pneumoconiosis.

Cytokeratins are structural proteins that form subunits of filaments. In measurement of CYFRA 21-1, monoclonal antibodies are used and fragments of cytokeratin-19 are measured. CYFRA 21-1 is an important marker in follow-up of Non SCLC patients (18,19). The cut-off value of CYFRA 21-1 is 3.3 ng/mL. It is increased in cases of acute pneumonia, tuberculosis, interstitial lung diseases, cirrhosis and renal failure (20). There was no difference between pneumoconiosis and non-pneumoconiosis cases. In addition, none of the cases had a value higher than the cutoff limits used for malign and benign lesions discrimination.

In conclusion, NSE and ferritin levels were found to be higher in coal workers with pneumoconiosis. According to our results, tumor markers are neither sensitive nor specific enough for the determination of early and low-grade pneumoconiosis. One of the interesting and important findings in this study is that NSE values were higher than 12.5 µg/mL in most of the pneumoconiosis cases (73.5%). The NSE cut-off value used in cancer screening of coal workers with pneumoconiosis should be increased in this setting.

REFERENCES

  1. Fishman AP, Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM. Fishman’s manual of pulmanory diseases and disorders. Tanoune LT. In: Occupational disorders. McGraw-Hill companies, Third Ed. 2002; part three: 205-57
  2. Chiyotani K, Saito K, Okubo T, Takahashi K. Lung cancer risk among pneumoconiosis patient in Japan, with special reference to silicotics. In: Occupational Exposure to Silica and Cancer Risk. Lyon IARC. 1990; 95-104
  3. Ferrigno D, Buccheri G, Biggi A. Serum tumour markers in lung cancer: history, biology and clinical applications. Eur Respir J 1994; 7: 186-97
  4. Ferrigno D, Buccheri G. Clinical applications of serum markers for lung cancer. Respir Med 1995; 89: 587-97
  5. Schneider J, Philipp M, Velcovsky HG, Morr H, Katz N. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19- fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Anticancer Res. 2003; 23: 885- 93
  6. Seemann MD, Beinert T, Furst H, Fink U. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions. Lung Cancer 1999; 26: 149-55
  7. Ebert W, Dienemann H, Fateh-Mogadam A, Scheulen M, Konietzko N, Schleich T, Bombardiere E. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembriyonic antigen, squamouse cell carcinoma antigen and neurone specific enolase in lung cancer. Results of an international muiticentre study. Eur J Clin Chem Biochem 1994; 32:189-199
  8. International Labour Office (ILO). Guidelines for the use of ILO international classification of radiographs of pneumoconioses. Occupational Safety and Health Series, No:48, Geneva: ILO, 1980
  9. Epler GR., McLoud TC, Gaensler EA, Mikus PJ, Carlington CB. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978; 298: 934
  10. Suganuma N, Kusaka Y, Hosoda Y et all. The Japanese Classification of Computed Tomography for pneumoconiosis with the ILO international classification of radiographs for pneumoconiosis. J Occup Health 2001; 43: 24-31
  11. Daniel WC, Stewart S. Tumor markers In: Tietz Fundamentals of Clinical Chemistry. Third Ed. Burtis CA, Ashwood ER. W.B. Saunders Company, Philadelphia USA; 1999: Chapter 23; 722-49
  12. Kuralay F, Tokgoz Z, Comlekci A. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin. Clin Chim Acta 2000; 300: 43-55
  13. Goldenberg DM, Neville AM, Carter AC, Go VL, Holyoke ED, Isselbacher KJ, Schein PS, Schwartz M: CEA (carcinoembryonic antigen): its role as a marker in the management of cancer. J Cancer Res Clin Oncol. 1981; 101: 23942
  14. Lamerz R: NSE (Neuronen- spezifische enolase), g-Enolase. In: Thomas L (ed) Clinical Laboratory Diagnosis, TH Books, Frankfurt, 1st Edition 1998: 97981
  15. Satoh H, Ishikawa H, Kurishima K, Yamashita YT, Ohtsuka M, Sekizawa K. Cut-off levels of NSE to differentiate SCLC from NSCLC. Oncol Rep 2002; 9: 581-83
  16. Pina TC, Zapata IT, Lopez JB, Perez JL, Paricio PP, Hernandez PM.Tumor markers in lung cancer: does the method of obtaining the cut-off point and reference population influence diagnostic yield? Clin Biochem 1999; 32: 467-72
  17. McGowan SE, Henley SA: Iron and ferritin contents and distrubition in human alveolar macrophages. J Lab Clin Med 1988; 111: 611-617
  18. Bodenmueller H: The biochemistry of CYFRA 21-1 and other cytokeratin-tests. Scand J Clin Lab Invest 1995; 55: 60-66 (Suppl 221)
  19. Ebert W, Leichtweis B, Schapöhler B, Muley T. The new tumormarker CYFRA is superior to SCC antigen and CEA in the primary diagnosis of lung cancer. Tumor Diagnostik und Therapie 1993; 14: 91-99
  20. Stieber P, Dienemann H, Hasholzner U et al. Comparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases. Int J Biol Markers. 1994; 9: 82-8
Copyright 2004 - Medical Investigations Society

The following images related to this document are available:

Photo images

[gm04005f2.jpg] [gm04005f3.jpg] [gm04005f1.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil